Monoclonal Immunoglobulin Deposition Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-03-30
Clinical Trial Update: Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis [NA]
Clinical trial update on BD followed by autologous stem cell transplant and maintenance BD for initial treatment of Monoclonal Immunoglobuli…